CN Patent

CN120981229A — 用于治疗先天性肾上腺皮质增生症的组合物和方法

Assigned to Crinetics Pharmaceuticals Inc · Expires 2025-11-18 · 0y expired

What this patent protects

提供了用于治疗先天性肾上腺皮质增生症(CAH)的组合物和方法。

USPTO Abstract

提供了用于治疗先天性肾上腺皮质增生症(CAH)的组合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN120981229A
Jurisdiction: CN
Classification: —
Expires: 2025-11-18
Drug substance claim: No
Drug product claim: No
Assignee: Crinetics Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.